Lung Diseases, Fungal: Clinical Trials

208 trials for Lung Diseases, Fungal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

128 completed, 24 unknown, 23 recruiting, 13 terminated. 42 Phase 3, 38 Not applicable, 33 Phase 2, 17 Phase 4, 15 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 342Completed 29, Terminated 4, Unknown 3, Recruiting 2, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1
Not applicable38Completed 31, Unknown 3, Not yet recruiting 2, Enrolling by invitation 1, Recruiting 1
Phase 233Completed 20, Terminated 7, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 417Unknown 5, Completed 4, Not yet recruiting 3, Terminated 2, Withdrawn 2, Recruiting 1
Phase 115Completed 12, Recruiting 1, Terminated 1, Withdrawn 1
Early Phase 11Unknown 1

Follow Lung Diseases, Fungal: new trials by email Literature Review of Lung Diseases, Fungal trials Research Report on Lung Diseases, Fungal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Platform Trial for Salvage Consolidation Therapy in Dimorphic Fungi
Oteseconazole - Coccidioidomycosis, Blastomycosis
Phase 2Not yet recruitingUniversity of Minnesota302026-12-012026-09-04
Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma
Depemokimab - Allergic Bronchopulmonary Aspergillosis, ABPA
Not applicableNot yet recruitingQianfoshan Hospital102026-11-012026-09-24
Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis
Tezepelumab - Allergic Bronchopulmonary Aspergillosis, Severe Asthma
Not applicableNot yet recruitingQianfoshan Hospital102026-09-012026-08-11
Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney Transplantation
Trimethoprim-Sulfamethoxazole (TMP-SMX) - Pneumocystis Jirovecii Pneumonia, Kidney Transplantation
Phase 4Not yet recruitingAnhui Provincial Hospital10842026-06-012026-06-01
Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)
Clindamycin + primaquine, Pentamidine, Atovaquone - Pneumocystis, Pneumocystis Infection
Phase 4Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre4162026-03-012026-01-21
How Long Should we Give Steroids for Patients With Severe PCP
Systemic corticosteroids - Pneumocystis Pneumonia, Pneumocystis
Phase 4Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre4162026-01-302026-01-09
A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA
The patients were treated with bronchoscopic airway clearance and amphotericin B spraying - ABPA, Allergic Bronchopulmonary Aspergillosis
RecruitingQianfoshan Hospital442026-01-102026-01-23
CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia
Caspofungin Acetate 50 MG, Physiologic saline - Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection
Phase 1 / Phase 2RecruitingUniversity Hospital, Tours1002025-12-022026-10-09
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
trimethoprim-sulfamethoxazole - Pneumocystis, Pneumocystis Pneumonia
Phase 3RecruitingTodd C. Lee MD MPH FIDSA4162025-11-282026-02-20
Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
FUNGAL-P Score Assessment - Pneumonia, Fungal Pneumonia
RecruitingAzienda Ospedaliero-Universitaria Careggi4002025-11-132026-07-02
Influenza A-associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit in China
IPA and non-IPA groups - ICU, Invasive Pulmonary Aspergillosis
CompletedJianfeng Xie5422025-11-012026-01-09
Corticosteroids for PJP in Non-HIV Immunocompromised Adults
Saline (0.9%, sterile, for infusion), Low Dose Corticosteroids, Moderate dose corticosteroids - Pneumocystis Jiroveci Pneumonia
Phase 3Not yet recruitingQingyuan Zhan2402025-09-082025-09-09
Pneumocystis Jirovecii Genotyping
Pneumocystis Pneumonia
Not yet recruitingNottingham University Hospitals NHS Trust702025-09-012025-06-27
Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis
Fasenra - Allergic Bronchopulmonary Aspergillosis, Severe Asthma
RecruitingQianfoshan Hospital202025-09-012026-04-21
Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors
Liver Cirrhosis, Viral Pneumonia
Active not recruitingUniversitaire Ziekenhuizen KU Leuven4502025-08-012026-03-04
Immune Status and Disease Control of Inflammatory Airway Diseases
Airway Inflammation, Chronic Obstructive Pulmonary Disease (COPD)
RecruitingFirst Affiliated Hospital of Ningbo University2002025-08-012026-03-25
Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
Biological sampling - Pneumocystis, Immunocompromised Patients
RecruitingAssistance Publique - Hôpitaux de Paris2402025-07-082026-04-23
Fungal Status and Prognosis in ABPA
ABPA, Allergic Bronchopulmonary Aspergillosis
RecruitingQianfoshan Hospital1142025-07-012026-07-08
Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
Allergic Bronchopulmonary Aspergillosis (ABPA)
RecruitingQianfoshan Hospital1402025-05-102025-07-04
iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine
Radiopharmaceutical: gallium-68-deferoxamine ([68Ga]Ga-DFO-B) - Pulmonary Aspergillosis, Chronic Pulmonary Aspergillosis
Phase 2CompletedRadboud University Medical Center102025-05-012026-08-18

Showing 20 of 208. Sign in to see all of them.

Narrower conditions

Pneumonia, Pneumocystis (107)  ·  HIV Infections (60)  ·  Acquired Immunodeficiency Syndrome (56)  ·  Invasive Pulmonary Aspergillosis (43)  ·  Aspergillosis, Allergic Bronchopulmonary (42)  ·  AIDS-Related Opportunistic Infections (30)  ·  Mycoses (18)  ·  AIDS-Related Complex (17)  ·  Pulmonary Aspergillosis (13)  ·  Aspergillosis (12)  ·  Asthma (12)  ·  Pneumonia (11)  ·  Blastomycosis (10)  ·  Respiratory Aspiration (9)

Broader conditions

Respiratory Tract Diseases (208)  ·  Bacterial Infections and Mycoses (207)  ·  Lung Diseases (207)  ·  Infections (203)  ·  Mycoses (190)  ·  Respiratory Tract Infections (171)  ·  Immune System Diseases (111)  ·  Pneumonia (101)  ·  Pneumocystis Infections (99)  ·  Aspergillosis (81)  ·  Pulmonary Aspergillosis (76)  ·  RNA Virus Infections (72)  ·  Virus Diseases (72)  ·  Urogenital Diseases (65)

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination (23)  ·  Pentamidine (22)  ·  Leucovorin (13)  ·  trimetrexate glucuronate (12)  ·  Itraconazole (11)  ·  Atovaquone (10)  ·  Dapsone (10)  ·  Voriconazole (9)  ·  Zidovudine (7)  ·  Caspofungin (6)  ·  Amphotericin B (5)  ·  Methylprednisolone (5)  ·  Trimethoprim (5)  ·  Blood Specimen Collection (4)  ·  Clindamycin (4)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (37)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (9)  ·  Qianfoshan Hospital (9)  ·  Fisons (5)  ·  U.S. Bioscience (5)  ·  University of Pittsburgh (5)  ·  Glaxo Wellcome (4)  ·  TFF Pharmaceuticals, Inc. (3)  ·  Universitaire Ziekenhuizen KU Leuven (3)  ·  Asan Medical Center (2)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Central Hospital, Nancy, France (2)  ·  GlaxoSmithKline (2)  ·  Jacobus Pharmaceutical (2)  ·  LyphoMed (2)

Countries

United States (85)  ·  France (32)  ·  China (30)  ·  Belgium (16)  ·  Germany (13)  ·  United Kingdom (13)  ·  Canada (12)  ·  India (12)  ·  Netherlands (9)  ·  Italy (7)  ·  Puerto Rico (7)  ·  Spain (6)  ·  Australia (5)  ·  Israel (5)  ·  South Africa (5)

Top investigators

Feinberg J (5)  ·  Alison Morris-Gimbel, MD (2)  ·  B Montgomery (2)  ·  Black JR (2)  ·  Dale Christensen, PhD (2)  ·  El-Sadr W (2)  ·  Emily G McDonald, MD MSc (2)  ·  Fischl M (2)  ·  Frame P (2)  ·  Jay K Kolls, MD (2)  ·  Joost Wauters, MD, PhD (2)  ·  Luskin-Hawk R (2)  ·  Masur H (2)  ·  Ptachcinski R (2)

Results publications

PMID 33027187, PMID 41151592, PMID 15504856, PMID 16304338, PMID 18046534, PMID 18230259, PMID 20607114, PMID 20946413, PMID 21729932, PMID 21732834, PMID 21854805, PMID 22548840, PMID 23359515, PMID 23940606, PMID 25203869, PMID 25376267, PMID 25603113, PMID 25927915, PMID 26050015, PMID 26302738, PMID 26585431, PMID 26872154, PMID 26935726, PMID 27011794, PMID 28530849, PMID 29313714, PMID 29331473, PMID 29514207, PMID 30049743, PMID 30561849, PMID 30776290, PMID 31548210, PMID 31633150, PMID 32194238, PMID 32391667, PMID 32407157, PMID 32457106, PMID 32479781, PMID 32653726, PMID 32671131, PMID 33005696, PMID 33213011, PMID 33293212, PMID 33438477, PMID 33538349, PMID 33549194, PMID 33586013, PMID 33744933, PMID 34349985, PMID 34682270

NIH funding

2017 (4), 2019 (3), 2016 (2), 2023 (2), P50HL084932 (2), 2018 (1), R01AI139032 (1), R01HL083461 (1), R01HL090339 (1), U01AI068632 (1)